文献速递临床试验与 GCP

基于虚拟现实与标准认知行为疗法治疗精神分裂症谱系障碍偏执症状的随机对照试验

Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial.
PubMed 文献 · Nat Med · 2025-08-13

该评估者设盲、随机平行组优效性试验比较VR-CBTp与标准CBTp治疗精神分裂症谱系障碍偏执症状的疗效,254例参与者随机接受十次VR-CBTp或CBTp,均叠加常规治疗。意向性治疗分析显示主要结局(治疗结束时Green偏执思维量表被害观念子量表)组间差异无统计学意义(效应估计2%支持VR-CBTp,95%CI -11%至+17%,Cohen's d=0.04,P=0.77)。结论:VR-CBTp在减轻精神分裂症谱系障碍相关偏执方面不优于CBTp。

要点

  • VR-CBTp与CBTp均为十次治疗,均叠加常规治疗。
  • 主要结局组间差异无统计学意义(P=0.77)。
  • 研究期间无死亡或涉及执法机构的暴力事件。

核心结论

  • VR-CBTp在减轻精神分裂症谱系障碍相关偏执方面不优于CBTp。

研究设计与样本

  • 评估者设盲、随机平行组优效性试验,比较VR-CBTp与标准CBTp。
  • 意向性治疗分析纳入254例参与者(VR-CBTp组n=126,CBTp组n=128)。
  • 两组均接受十次治疗,均叠加常规治疗。
  • 结局在基线、治疗结束时及治疗结束后6个月随访时评估。

主要发现

  • 主要结局为治疗结束时Green偏执思维量表被害观念子量表,组间差异无统计学意义(效应估计2%支持VR-CBTp,95%CI -11%至+17%,Cohen's d=0.04,P=0.77,基于对数转换数据指数化)。
  • 研究期间无死亡或涉及执法机构的暴力事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Paranoia is a distressing and prevalent symptom in schizophrenia spectrum disorders. Virtual reality-based cognitive behavioral therapy for paranoia (VR-CBTp) has been proposed to augment behavioral interventions by providing controlled and safe virtual environments in which social situations inducing paranoid anxiety can be manipulated, allowing for new therapeutical possibilities such as gradual exposure and repetition. This assessor-masked, randomized parallel group superiority trial investigated the efficacy of VR-CBTp compared to standard CBTp. Participants were randomized to receive ten sessions of VR-CBTp or CBTp, both on top of treatment as usual. Intention-to-treat analyses included 254 participants (VR-CBTp: n = 126, CBTp: n = 128). Outcomes were assessed at baseline, treatment cessation and follow-up (6 months after treatment cessation). The primary outcome was Ideas of Persecution subscale from the Green Paranoid Thoughts Scale, measured at treatment cessation. There was not a statistically significant between-group difference on the primary outcome at endpoint (effect estimate: 2% in favor of VR-CBTp; 95% confidence interval: -11% to +17%; Cohen's d = 0.04; P = 0.77, based on exponentiated log-transformed data). No deaths or violent incidents involving law enforcement occurred during the study. In conclusion, VR-CBTp was not superior to CBTp in reducing schizophrenia-spectrum-disorders-related paranoia. ClinicalTrials.gov registration: NCT04902066 .

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Jeppesen UN, Vernal DL, Due AS, et al. Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial. Nat Med. 2025. PMID: 40804323. doi:10.1038/s41591-025-03880-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。